Back to Agenda
Evolution of Electronic Product Information in LATAM: Challenges and Opportunities to Improve the Value of Healthcare
Session Chair(s)
Leonardo Semprun, PharmD
Global Regulatory Policy Lead-LatAm
MSD, Panama
This session provides a comprehensive overview of the status/evolution of the concept of electronic product information (ePI) in LATAM from multiple perspectives, including industry, international regulatory bodies, and various stakeholders involving patients and healthcare professionals (HCPs). It also reviews some of the relevant initiatives undertaken in Low to Medium Income countries and their benefits and potential.
Learning Objective : Identify the impact of electronic product information (ePI) hybrid pilots and regulatory framework evolution in LATAM countries; Discuss relevant initiatives undertaken in Low to medium income countries; Examine industry motivations and challenges in implementing ePI pilots; Describe the evolving landscape (efforts of HA's based on international standard for ePI, regulatory advancements made to ensure an optimal experience for patients/ HCPs, implications of these challenges on healthcare.
Speaker(s)
Advancing eLabeling in Brazil: Drivers, Challenges, and Opportunities for Digital Transformation
Nélio Cézar de Aquino, MSc
ANVISA, Brazil
General Manager of Medicines
Bridging the Digital Gap: Advancing Health Digital Agenda through ePI in Low to Middle Income Countries (LMIC)
Rutendo Kuwana, RPh
World Health Organization (WHO), Switzerland
Team Lead, Incidents and Substandard/Falsified Medical Products
Industry and Society Outlook in Brazil: Exploring eLabeling Perspectives
Rosana M. Mastellaro, PharmD, RPh
Sindusfarma, Brazil
Director, Technical Regulatory Affairs and Innovation
Navigating the Roadmap to eLabeling implementation: Insights from a Global Pharmaceutical Company
Maria Cristina Mota Pina, MBA
AbbVie, United States
Head, Regulatory Policy for Emerging Markets -Japan and Australia
Have an account?